Recall Register

GETINGE US SALES LLC: FDA recalls

Newest recall start date in this list: . Maquet Cardiopulmonary GmbH / Getinge Quadrox-iD Pediatric Diffusion Membrane Oxygenator with Bioline Coating, Sterile REF: BEQ-HMOD 30000

FDA enforcement events from 2017 to 2019; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name GETINGE US SALES LLC as the recalling firm in 9 events. The events have 12 product records. The recalls started from 2017 to 2019. All the events are device recalls. By FDA enforcement events, GETINGE US SALES LLC is number 387 of 1,629 firms that have a page. Events that GETINGE US SALES LLC started: none in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025. Class II is 88.9% of its events and 73.7% of all FDA events.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

9 events, newest first.

FDA enforcement events of GETINGE US SALES LLC
InitiatedProduct (first record)TypeClassRecordsStatus
13 Nov 2019Maquet Cardiopulmonary GmbH / Getinge Quadrox-iD Pediatric Diffusion Membrane Oxygenator with Bioline Coating, Sterile REF: BEQ-HMOD 30000DeviceClass II1Ongoing
22 Aug 2019The HEMASHIELD PLATINUM Woven Double Velour Vascular Graft is a woven double velour polyester graft impregnated with highly purified bovine collagen. The HEMASHIELD PLATINUM Woven Double Velour Vascular Graft is designed to reduce bleeding at implant and thereby eliminates the operative preclotting step, including…DeviceClass II1Terminated
22 Jul 2019Getinge MCC Flow i Disposable CO2 absorber, used in anesthesia systems.DeviceClass II1Terminated
5 Jun 2019PulsioFlex Monitoring System, Part Number: 6882747, Model Number: PC400 3 R0. Usage: The PulsioFlex Monitoring System is indicated in patients where cardiovascular and circulatory volume status monitoring is necessary. If a patient s biometric data are entered, the PulsioFlex Monitor presents the derived parameters…DeviceClass II1Terminated
20 Mar 2019Maquet Servo-I Ventilator System -EDI CATHETER PHT Free 6Fr/49cm 5/pkg Product Code/REF Number: 6685775 Product Usage: The Edi Catheter is a single-use naso-gastric feeding tube with an electrode array of ten electrodes. The Edi Catheter is intended for: - Detecting diaphragmatic electrical activity, (Edi signals) by…DeviceClass III1Terminated
8 Jan 2019Maquet XS Flat Screen Monitor Holder, XS32 SPE, Configuration Part Number ARD22201040A Product Usage: This product is designed to support one or two medical grade flat screen(s) alone or in association with surgical lights.DeviceClass II4Terminated
7 Feb 2018VOLISTA StandOP Surgical Light; Model numbers VLT600 SF AIM STP, VLT600 DF AIM STP, Ref. codes ARD568811901, ARD568811911 ARD568811951, ARD568811961 The device is designed to illuminate the body of a patient during surgical operations, diagnostics and treatment. These surgical lights may be installed in surgical…DeviceClass II1Terminated
3 Jan 2018HEMASHIELD Knitted Double Velour Cardiovascular FabricDeviceClass II1Terminated
16 Nov 2017ALM XTEN Surgical Light intended to provide visible illumination for the surgical field or for the examination of the patient. Part Numbers: ARD567801093, ARD567801094DeviceClass II1Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

GETINGE US SALES LLC: events for each product type
TypeEvents
Device9
GETINGE US SALES LLC: events in each class
ClassEvents
Class II8
Class III1
Share of the events of the firm in Class I
0%
Share of all events on the register in Class I
18%
Events with the status Ongoing
1

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of GETINGE US SALES LLC, by the year that the recall started. The largest year is 2019, with 6 events.

Official channels

Cite this page

Recall Register. GETINGE US SALES LLC: FDA recalls. https://recallregister.com/firm/getinge-us-sales-llc/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
NJ

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of GETINGE US SALES LLC have?
Class II: 8 events. Class III: 1 event. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of GETINGE US SALES LLC?
FDA event 84352, which the firm started on 13 Nov 2019. The first product in the record is: Maquet Cardiopulmonary GmbH / Getinge Quadrox-iD Pediatric Diffusion Membrane Oxygenator with Bioline Coating, Sterile REF: BEQ-HMOD 30000
How many FDA recalls of GETINGE US SALES LLC have the status Ongoing?
1 event has the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.